Showing results (11-20 of 233) with videos related to
Sort By:
Pageof 24
Medecine Sciences : M/S|December 24, 2011
[ADAMTS13, von Willebrand factor specific cleaving protease]Agnès Veyradier, Paul CoppoHematology. American Society of Hematology. Education Program|December 6, 2015
Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchangePaul Coppo, Antoine Froissart, British Journal of Haematology|June 9, 2023
Caplacizumab: A game changer also in pregnancy-associated immune-mediated thrombotic thrombocytopenic purpura?Paul Coppo, Bérangère S Joly, Presse Medicale (Paris, France : 1983)|December 13, 2006
[Acquired idiopathic thrombotic thrombocytopenic purpura: arguments for an autoimmune disease]Paul Coppo, Agnès Veyradier, Matthieu Monge, et al.Presse Medicale (Paris, France : 1983)|November 25, 2019
Therapeutic plasma exchange in thrombotic thrombocytopenic purpuraAdrien Picod, François Provôt, Paul CoppoZookeys|January 9, 2026
A new species of Cheironitis van Lansberge, 1875 (Coleoptera, Scarabaeidae, Onitini) and the first record of Cheironitis moeris (Pallas, 1787) from ChinaYuHeng Wang, Olivier Montreuil, Paul CoppoLa Revue Du Praticien|January 23, 2026
[Microangiopathies thrombotiques]Léo Guénnoun, Adrien Picod, Paul CoppoCurrent Opinion in Pediatrics|February 21, 2013
Thrombotic thrombocytopenic purpura in childrenChantal Loirat, Paul Coppo, Agnès VeyradierJournal of Thrombosis and Haemostasis : JTH|November 25, 2020
Should all patients with immune-mediated thrombotic thrombocytopenic purpura receive caplacizumab?Adrien Picod, Agnès Veyradier, Paul CoppoBMC Nephrology|July 21, 2021
Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centreMaximilien Grall, Florence Daviet, Noémie Jourde Chiche, et al.Pageof 24